LEADER 02087nam  2200493 a 450 
001 9910790211203321
005 20200520144314.0
010   $a1-61470-069-9
035   $a(CKB)2670000000149454
035   $a(EBL)3019757
035   $a(SSID)ssj0000690231
035   $a(PQKBManifestationID)12331028
035   $a(PQKBTitleCode)TC0000690231
035   $a(PQKBWorkID)10620628
035   $a(PQKB)11099867
035   $a(MiAaPQ)EBC3019757
035   $a(Au-PeEL)EBL3019757
035   $a(CaPaEBR)ebr10671322
035   $a(OCoLC)846943406
035   $a(EXLCZ)992670000000149454
100   $a20081119d2009      uy             0
101 0 $aeng
135   $aur|n|---|||||
181   $ctxt
182   $cc
183   $acr
200 00$aImmunologic adjuvant research$b[electronic resource] /$fAntonio H. Benvenuto, editor
210   $aHauppauge, N.Y. $cNova Science$dc2009
215   $a1 online resource (140 p.)
300   $aDescription based upon print version of record.
311   $a1-60692-399-4 
320   $aIncludes bibliographical references and index.
327   $aAdjuvants in cancer vaccinations / Ralf Kircheis, Andreas Nechansky -- TLR agonists as immune adjuvants / Yanal Murad, Bara Sarraj -- Modulating immune response with CpG-oligodeoxynucleotide through the skin / Joe Inoue, Yukihiko Aramaki -- Immunopotentiating reconstituted influenza virosomes as safe and potent antigen-delivery system for synthetic peptides in vaccines development / Claudia A. Daubenberger ... [et al.] -- Vaccine adjuvants : priorities and challenges / Ali M. Harandi, Ole F. Olesen -- The involvement of interleukin-6 in the augmentation of immune response by immunologic adjuvants / Masahiko Mihara, Hiroto Yoshida.
606   $aImmunological adjuvants
615  0$aImmunological adjuvants.
676   $a571.9/645
701   $aBenvenuto$b Antonio$f1945-$01573498
801  0$bMiAaPQ
801  1$bMiAaPQ
801  2$bMiAaPQ
906   $aBOOK
912   $a9910790211203321
996   $aImmunologic adjuvant research$93849245
997   $aUNINA